NCT05417750
- Conditions
- Advanced Solid Tumor, Adverse Drug Event, Chemically-Induced Disorders, +5 more
- Locations
-
- Chinese PLA General Hospital Beijing, Beijing Municipality, China
Clinical trial condition
Immunotherapy
Explore clinical trials studying Immunotherapy. Study availability and eligibility vary by location and protocol.
216 public trials
103 recruiting studies
Immunotherapy trial results
NCT05775796
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
NCT05304546
- Conditions
- BRAF V600E, Immunotherapy, Malignant Melanoma, +14 more
- Locations
-
- Sheba Medical Center Ramat Gan, Israel
Completed
Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer
NCT04821765
- Conditions
- Chemoradiotherapy, Digestive System Diseases, Digestive System Neoplasms, +10 more
- Locations
-
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC) Beijing, Beijing Municipality, China
- Department 4th of Radiation Oncology, Anyang Cancer Hospital Anyang, Henan, China
NCT06818097
- Conditions
- Advanced HCC, Chemotherapy, Efficacy and Safety, +3 more
- Locations
-
- Sen Memorial Hospital Guangzhou, Guangdong, China
NCT06573424
- Conditions
- Colon Cancer, Colonic Diseases, Colonic Neoplasms, +10 more
- Locations
-
- Daping Hospital, Third Military Medical University Chongqing, China
NCT05273255
- Conditions
- Cancer, Fecal Microbiota Transplantation, Immune Checkpoint Inhibitors, +2 more
- Locations
-
- University of Zurich, University Hospital Zurich Zurich, Switzerland
NCT05223088
- Conditions
- Gastrict Cancer, Immunotherapy
- Locations
-
- Fujian cancer hospital Fuzhou, China
NCT06794099
- Conditions
- Complete Response, Disease Attributes, Disease Progression, +6 more
- Locations
-
- Peking University Cancer Hospital & Institute Beijing, Beijing Municipality, China
NCT05807893
- Conditions
- Bevacizumab, Brain Diseases, Brain Metastases, +17 more
- Locations
-
- Likun Chen Guangzhou, Guangdong, China